AstraZeneca Aktie
145,65
EUR
-1,50
EUR
-1,02
%
127,24
GBP
-0,58
GBP
-0,45
%
Werbung
AstraZeneca Aktie Analyse
25.10.12 | AstraZeneca neutral | Citigroup Corp. | |
23.10.12 | AstraZeneca neutral | Exane-BNP Paribas SA | |
17.10.12 | AstraZeneca buy | UBS AG | |
16.10.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
11.10.12 | AstraZeneca hold | Deutsche Bank AG | |
05.10.12 | AstraZeneca verkaufen | Independent Research GmbH | |
04.10.12 | AstraZeneca reduce | Nomura | |
04.10.12 | AstraZeneca neutral | Exane-BNP Paribas SA | |
Werbung
|
|||
03.10.12 | AstraZeneca underperform | Credit Suisse Group | |
02.10.12 | AstraZeneca hold | Deutsche Bank AG | |
26.09.12 | AstraZeneca overweight | Morgan Stanley | |
19.09.12 | AstraZeneca buy | UBS AG | |
12.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
10.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
04.09.12 | AstraZeneca neutral | Citigroup Corp. | |
29.08.12 | AstraZeneca neutral | Goldman Sachs Group Inc. | |
29.08.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
29.08.12 | AstraZeneca neutral | Sarasin Research | |
28.08.12 | AstraZeneca hold | Deutsche Bank AG | |
27.08.12 | AstraZeneca hold | Deutsche Bank AG | |
21.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
17.08.12 | AstraZeneca underperform | Credit Suisse Group | |
16.08.12 | AstraZeneca neutral | Goldman Sachs Group Inc. | |
06.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
02.08.12 | AstraZeneca reduce | Nomura | |
27.07.12 | AstraZeneca buy | UBS AG | |
27.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
19.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
18.07.12 | AstraZeneca underperform | Credit Suisse Group | |
18.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
18.07.12 | AstraZeneca reduce | Nomura | |
16.07.12 | AstraZeneca buy | UBS AG | |
12.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
03.07.12 | AstraZeneca underperform | Credit Suisse Group | |
03.07.12 | AstraZeneca neutral | Banc of America Securities-Merrill Lynch | |
03.07.12 | AstraZeneca buy | UBS AG | |
03.07.12 | AstraZeneca reduce | Nomura | |
02.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
02.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
02.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
28.06.12 | AstraZeneca hold | Deutsche Bank AG | |
28.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
21.06.12 | AstraZeneca underperform | Credit Suisse Group | |
20.06.12 | AstraZeneca neutral | Citigroup Corp. | |
19.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
15.06.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
11.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
08.06.12 | AstraZeneca buy | UBS AG | |
05.06.12 | AstraZeneca underperform | Credit Suisse Group |
Werbung
Werbung